Skip Navigation

This Article
Right arrow Full Text (PDF )
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Koper, J. W.
Right arrow Articles by Lamberts, S. W.J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Koper, J. W.
Right arrow Articles by Lamberts, S. W.J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 9, No. suppl_1, pp. 190-194, 1994
© 1994 European Society of Human Reproduction and Embryology

Meningiomas, epidermal growth factor and progesterone

Jan W. Koper and Steven W.J. Lamberts

Department of Medicine, Erasmus University Rotterdam, University Hospital Dijkzigt 40 Dr Molewaterplein, Room Bd 277, 3015 GD Rotterdam, The Netherlands

Meningiomas are common brain tumours which are generally benign, well circumscribed and slow growing. In a minority of patients complete surgical removal of the tumour is not possible, and re-growth of tumour tissue is a major clinical problem. The presence of receptors for progester one in a large proportion of human meningioma tissues is well established. The occurrence of increased rates of growth of meningiomas during pregnancy suggests the existence of a relationship between high progesterone concentrations and the growth of meninglomas. These observations suggest that the use of antiprogestins may be of value in the treatment of meningiomas. However, experiments with cultured meningioma tissue (cells or explants) have shown only minimal effects of progesterone. It has been shown recently that many meningionias have receptors for epidermal growth factor. We have investigated the response of cultured human meningioma cells to epidermal growth factor and the modulation of this response by progesterone and the progesterone-receptor blocking agent mifepristone (RU486). The results suggest that the presence of progesterone in the culture medium increases the sensitivity of meningioma cells to specific mitogenic stimuli without having direct mitogenic effects, whereas mifepristone can counteract the stimulating effects of progesterone.

Key words: cell culture/EGF/meningioma/progesterone/RU486


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.